Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Barrera

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Nature Genetics|November 9, 2023
Transcriptional and epigenetic regulators of human CD8<sup>+</sup> T cell function identified through orthogonal CRISPR screensSean R McCutcheon, Adam M Swartz, Michael C Brown, et al.
Science (New York, N.Y.)|September 25, 2025
Mechanosensitive genomic enhancers potentiate the cellular response to matrix stiffnessBrian D Cosgrove, Lexi R Bounds, Carson Key Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2023
Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13Hazel X Ang, Natalia Sutiman, Xinyue L Deng, et al.
Genome Research|August 12, 2018
Glucocorticoid receptor recruits to enhancers and drives activation by motif-directed bindingIan C McDowell, Alejandro Barrera, Anthony M D'Ippolito, et al.
NPJ Precision Oncology|May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.
Reumatologia Clinica|June 10, 2026
Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial HypertensionKarla Chacón-Abril, Margarita Portela-Hernández, Luis Daniel Fajardo-Hermosillo, et al.
Nature Methods|August 3, 2021
Transgenic mice for in vivo epigenome editing with CRISPR-based systemsMatthew P Gemberling, Keith Siklenka, Erica Rodriguez, et al.
American Journal of Medical Genetics. Part A|October 4, 2024
Promoter Deletion Leading to Allele Specific Expression in a Genetically Unsolved Case of Primary Ciliary DyskinesiaM Makenzie Beaman, Weining Yin, Amanda J Smith, et al.
Nature Communications|July 17, 2021
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancerStefan Prekovic, Karianne Schuurman, Isabel Mayayo-Peralta, et al.
Cancer Discovery|October 31, 2015
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyElena Sotillo, David M Barrett, Kathryn L Black, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Nature Genetics|November 9, 2023
Transcriptional and epigenetic regulators of human CD8<sup>+</sup> T cell function identified through orthogonal CRISPR screensSean R McCutcheon, Adam M Swartz, Michael C Brown, et al.
Science (New York, N.Y.)|September 25, 2025
Mechanosensitive genomic enhancers potentiate the cellular response to matrix stiffnessBrian D Cosgrove, Lexi R Bounds, Carson Key Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2023
Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13Hazel X Ang, Natalia Sutiman, Xinyue L Deng, et al.
Genome Research|August 12, 2018
Glucocorticoid receptor recruits to enhancers and drives activation by motif-directed bindingIan C McDowell, Alejandro Barrera, Anthony M D'Ippolito, et al.
NPJ Precision Oncology|May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.
Reumatologia Clinica|June 10, 2026
Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial HypertensionKarla Chacón-Abril, Margarita Portela-Hernández, Luis Daniel Fajardo-Hermosillo, et al.
Nature Methods|August 3, 2021
Transgenic mice for in vivo epigenome editing with CRISPR-based systemsMatthew P Gemberling, Keith Siklenka, Erica Rodriguez, et al.
American Journal of Medical Genetics. Part A|October 4, 2024
Promoter Deletion Leading to Allele Specific Expression in a Genetically Unsolved Case of Primary Ciliary DyskinesiaM Makenzie Beaman, Weining Yin, Amanda J Smith, et al.
Nature Communications|July 17, 2021
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancerStefan Prekovic, Karianne Schuurman, Isabel Mayayo-Peralta, et al.
Cancer Discovery|October 31, 2015
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyElena Sotillo, David M Barrett, Kathryn L Black, et al.
Pageof 9